Explore 3 Stock Ideas & Industry Insights Download Free Report
Hikma Pharmaceuticals (LSE:HIK) has filled a key boardroom role, announcing on 24 September that Rebecca Hall will join as chief financial officer and executive director. The appointment comes at a time when investors in the FTSE 250 pharmaceuticals group are focused onMargintrends in its …
• LSE:EDX was shown down 6.67% on 9 October 2026, making it one of the notable fallers in the session.
• The company operates in diagnostic testing and precision-medicine markets.
Proteome Sciences plc (LSE:PRM) recorded a -4.58% move lower on 9 October 2026. That places the stock among the notable fallers in the session and raises the question of whether the move reflects company-specific news, a reassessment of its outlook, broader small-cap weakness or …
TheraCryf Plc (LSE:TCF) recorded a -5.56% move lower on 9 October 2026. That places the stock among the notable fallers in the session and raises the question of whether the move reflects company-specific news, a reassessment of its outlook, broader small-cap weakness or trading …
• LSE:MET was shown down 8.33% on 9 October 2026, making it one of the notable fallers in the session.
Sareum Holdings — LSE:SAR — is in focus after the latest corporate development: Capital Access Window and funding flexibility. The company is traded on the London Stock Exchange’s AIM market, rather than being a constituent of the FTSE 100 or FTSE 250. That market …
Arecor Therapeutics is in focus following half-year results investor presentation. The announcement matters because it may influenceShareholderexpectations,Capitalallocation, governance or the company’s strategic direction. Investors should separate the confirmed transaction or disclosure from assumptions about future performance.
Genus (LSE:GNS), the FTSE 250 animal genetics specialist, has been executing a share buyback since September, with weekly transaction notices including one on 5 October. The programme follows a set of full-year results that showed a marked improvement in profitability and a much firmer …
Verici Dx plc (LSE:VRCI) announced on 8 October 2026 the launch of a proposed placing and notice of a general meeting. The company is seeking about £8.0 million before fees, or about £7.4 million net, through the issue of 4,000,000,000 new ordinary shares at …
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…